- Home
- AKRO vs WRBY Comparison
AKRO vs WRBY Comparison
Compare AKRO & WRBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AKRO
- WRBY
- Stock Information
- Founded
- AKRO 2017
- WRBY 2010
- Country
- AKRO United States
- WRBY United States
- Employees
- AKRO N/A
- WRBY N/A
- Industry
- AKRO Biotechnology: Pharmaceutical Preparations
- WRBY Ophthalmic Goods
- Sector
- AKRO Health Care
- WRBY Health Care
- Exchange
- AKRO Nasdaq
- WRBY Nasdaq
- Market Cap
- AKRO 3.9B
- WRBY 2.1B
- IPO Year
- AKRO 2019
- WRBY 2021
- Fundamental
- Price
- AKRO $51.77
- WRBY $22.24
- Analyst Decision
- AKRO Strong Buy
- WRBY Buy
- Analyst Count
- AKRO 6
- WRBY 15
- Target Price
- AKRO $82.50
- WRBY $23.33
- AVG Volume (30 Days)
- AKRO 1.7M
- WRBY 1.9M
- Earning Date
- AKRO 08-08-2025
- WRBY 08-07-2025
- Dividend Yield
- AKRO N/A
- WRBY N/A
- EPS Growth
- AKRO N/A
- WRBY N/A
- EPS
- AKRO N/A
- WRBY N/A
- Revenue
- AKRO N/A
- WRBY $795,094,000.00
- Revenue This Year
- AKRO N/A
- WRBY $16.13
- Revenue Next Year
- AKRO N/A
- WRBY $13.87
- P/E Ratio
- AKRO N/A
- WRBY N/A
- Revenue Growth
- AKRO N/A
- WRBY 13.94
- 52 Week Low
- AKRO $21.02
- WRBY $12.46
- 52 Week High
- AKRO $58.40
- WRBY $28.68
- Technical
- Relative Strength Index (RSI)
- AKRO 48.51
- WRBY 59.16
- Support Level
- AKRO $51.08
- WRBY $21.48
- Resistance Level
- AKRO $57.35
- WRBY $22.52
- Average True Range (ATR)
- AKRO 2.17
- WRBY 0.74
- MACD
- AKRO -0.82
- WRBY -0.14
- Stochastic Oscillator
- AKRO 8.17
- WRBY 70.27
About AKRO Akero Therapeutics Inc.
Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis (MASH), or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that have the potential to address the core processes underlying NASH pathogenesis.
About WRBY Warby Parker Inc.
Warby Parker Inc is a mission-driven, lifestyle brand that operates at the intersection of design, technology, healthcare, and social enterprise. The company predominantly derives revenue from the sales of eyewear products, optical services, and accessories. The firm sells products and services through its stores, website, and mobile apps. Revenue generated from eyewear products includes the sales of prescription and non-prescription optical glasses and sunglasses, contact lenses, eyewear accessories, and expedited shipping charges.